speb/financial-data huggingface dataset:
CATR.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -2471000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Goodwill: 5241000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 5640000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 29477000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 29477000000.00
CATR.TO income_statement (annual, 2024-12-31) — Gross Profit: 23324000000.00
CATR.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CATR.TO income_statement (annual, 2024-12-31) — Interest Expense: 512000000.00
CATR.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 512000000.00
CATR.TO income_statement (annual, 2024-12-31) — Interest Income: 482000000.00
CATR.TO income_statement (quarterly, 2024-12-31) — Interest Income: 120000000.00
CATR.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 482000000.00
CATR.TO income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 120000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Inventory: 16827000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 58003000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2453000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 20000000.00
CATR.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 5000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 10283000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 612000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 612000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: -103000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: -103000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 27454000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 27351000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 10283000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -9316000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 14132000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 14132000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 3000000.00
CATR.TO income_statement (annual, 2024-12-31) — Minority Interests: 4000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -61000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -7677000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Net Debt: 31623000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Income: 10792000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 10792000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 10788000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 10792000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 10792000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 10788000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 10788000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Interest Income: -512000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 1626000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 799000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 967000000.00
CATR.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -512000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -41000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -1525000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Net PPE: 13361000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 722000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -168000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 13851000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 14467000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 3312000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 3312000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3757000000.00
CATR.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 15446000000.00
CATR.TO income_statement (annual, 2024-12-31) — Normalized Income: 10316381365.44
CATR.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 12035000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 10000000.00
CATR.TO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -154000000.00
CATR.TO income_statement (annual, 2024-12-31) — Operating Income: 13072000000.00
CATR.TO income_statement (annual, 2024-12-31) — Operating Revenue: 64809000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 477932024.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 3119000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 6665000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2909000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -2471000000.00
CATR.TO income_statement (annual, 2024-12-31) — Other Income Expense: 813000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 399000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 564000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5302000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 4890000000.00
CATR.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 221000000.00
CATR.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 1478000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Other Properties: 5701000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 5701000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Payables: 8349000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 15983000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: -154000000.00
CATR.TO income_statement (annual, 2024-12-31) — Pretax Income: 13373000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CATR.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -61000000.00
CATR.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 6000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1529000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 7060000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Receivables: 18847000000.00
CATR.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 41485000000.00
CATR.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2153000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -9316000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -7697000000.00
CATR.TO income_statement (annual, 2024-12-31) — Research And Development: 2107000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 59352000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 3155000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 722000000.00
CATR.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 6667000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Share Issued: 814894624.00
CATR.TO income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CATR.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 19491000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 13851000000.00
CATR.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 116381365.44
CATR.TO income_statement (annual, 2024-12-31) — Tax Provision: 2629000000.00
CATR.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.20
CATR.TO balance_sheet (annual, 2024-12-31) — Total Assets: 87764000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 46945000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Total Debt: 38409000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 19494000000.00
CATR.TO income_statement (annual, 2024-12-31) — Total Expenses: 51737000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 68270000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 42082000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 35998000000.00
CATR.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 13072000000.00
CATR.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 592000000.00
CATR.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 592000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 336962600.00
CATR.TO balance_sheet (annual, 2024-12-31) — Treasury Stock: 44331000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Work In Process: 1438000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Working Capital: 13410000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 2379000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 14249000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 7792000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 18771000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 8757421634.00
CATR.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.23
CATR.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 6896000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -918000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -918000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6043000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3562000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3562000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -674000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4496000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -175000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1289000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 401000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -1342000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -990000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 69000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -300000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 713000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: 401000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -941000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 155000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1294000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3382000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 6043000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -674000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 18067000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -3724000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 9291000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 6249000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 43019000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 12769000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 12769000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2951000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2951000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 32595000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -38000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -38000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 540000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 540000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 8797990864.00
CATR.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.23
CATR.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2003000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 0.00
CATR.TO income_statement (quarterly, 2025-03-31) — EBIT: 2686000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — EBITDA: 3226000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: 7000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 54000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 3575000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 3568000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4496000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 9228000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 371000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
CATR.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 84000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2205000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 5270000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5631000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 4958000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 116000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 116000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 17862000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 56655000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -175000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 2633000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 25819000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 25819000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 2633000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1797000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 12000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -3724000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 35026000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Income: 2003000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2003000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2003000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2003000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2003000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 2003000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2003000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -116000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 744000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -98000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 836000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -116000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -162000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 13432000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 149000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -934000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 12436000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 14713000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 3334000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 3334000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 3575000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3142000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 1937761089.49
CATR.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1289000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Operating Income: 2579000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 14249000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 471041788.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2824000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 12769000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2834000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2205000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 107000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 361000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 78000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4845000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4915000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 23000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 306000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Payables: 7792000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 14041000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 2570000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -179000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 7199000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 18771000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 9291000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 540000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1797000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -3724000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Research And Development: 480000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 61356000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Sale Of Business: 12000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 923000000.00
CATR.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 149000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1593000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 814894624.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 18067000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 12436000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 18761089.49
CATR.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 574000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
CATR.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 84974000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 43886000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 38588000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 18070000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 11670000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 66904000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 41955000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 34309000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 2579000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 84000000.00
CATR.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 84000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 343852836.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 47127000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Work In Process: 1435000000.00
CATR.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 10424000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 2566000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 16569000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8563000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 19851000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 8661530725.00
CATR.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.25
CATR.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3568000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -955000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -955000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6143000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 5442000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 5442000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -662000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 151000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1332000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 3122000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 572000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 525000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -649000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -159000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -237000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 563000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 572000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1097000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -474000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 141000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1941000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 6143000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -662000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 18661000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -823000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 11143000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 6825000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 46755000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 12800000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 12800000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 3412000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 3412000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 34934000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -72000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -72000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 554000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 554000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 8694723732.00
CATR.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.25
CATR.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2179000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 707000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — EBIT: 2944000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — EBITDA: 3498000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: 7000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -61000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 3611000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 5448000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 151000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 9591000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2167000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
CATR.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -16000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1684000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 5331000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 5652000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 5426000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 126000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 126000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 18595000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 59409000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1332000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 3074000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 27948000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 27948000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 3074000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -2371000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 2000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -823000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 35306000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Income: 2179000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2179000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2179000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2179000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2179000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2179000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2179000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -126000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -55000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 1709000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 703000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -126000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -538000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 13896000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 216000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 1006000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 13009000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 15442000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 3427000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 3427000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 3611000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3514000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 2191320000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 3122000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Operating Income: 2860000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 16569000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 468478923.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2867000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 12800000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2627000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1684000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 84000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 321000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 320000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5153000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 5169000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 100000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 321000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Payables: 9270000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 16095000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 2818000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -460000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 7517000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 19851000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 11143000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 554000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -2371000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -823000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Research And Development: 551000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 62160000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 405000000.00
CATR.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 216000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1694000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 814894624.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 18661000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 13009000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -3680000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 646000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
CATR.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 90325000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 46609000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 40748000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 18663000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 13709000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 71662000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 43570000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 36728000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 2860000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -16000000.00
CATR.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -16000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 346415701.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 47958000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Work In Process: 1487000000.00
CATR.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 11821000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 2567000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 17638000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8729000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 20461000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 5448000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1071000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -1071000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6223000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7538000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 7538000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -707000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -305000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1320000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 3737000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 113000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 572000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -376000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -48000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 182000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 373000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 113000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 685000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -469000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 347000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2112000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 6223000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -707000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 20658000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -342000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 12019000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 7313000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 49818000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 13798000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 13798000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3391000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3391000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 35991000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 410000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 410000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 570000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 570000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2300000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 0.00
CATR.TO income_statement (quarterly, 2025-09-30) — EBIT: 3260000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — EBITDA: 3830000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 8000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -16000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 3664000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 7544000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -305000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 9325000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 2666000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 0.00
CATR.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 102000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1723000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 5329000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 5610000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 5619000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 133000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 133000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 18958000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 62192000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1320000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 2747000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 27736000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 27736000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 2747000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -2037000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 1000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Minority Interests: 1000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -342000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 33996000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Income: 2300000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2300000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2299000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2300000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2300000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2299000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2299000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -133000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -61000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 744000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 710000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -133000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -367000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 14310000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 179000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 34000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 15048000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 15603000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 3000000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 3000000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 3664000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3728000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 2225269587.46
CATR.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 3737000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Operating Income: 3052000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 17638000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 467979596.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2861000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 13798000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2760000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1723000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 208000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 281000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 111000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5381000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 5672000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 106000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 190000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Payables: 8729000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 16042000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 3127000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -678000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 7878000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 20461000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 12019000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 570000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -2037000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -342000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Research And Development: 555000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 64460000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 617000000.00
CATR.TO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 179000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1822000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 814894624.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 20658000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 15048000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 27269587.46
CATR.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 836000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
CATR.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 93722000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 48394000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 41534000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 20659000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 14586000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 73063000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 43904000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 37072000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 3052000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 102000000.00
CATR.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 102000000.00
CATR.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 346915028.00